Health-related quality of life and quality-adjusted progression free survival for carfilzomib and dexamethasone maintenance following salvage autologous stem-cell transplantation in patients with multiple myeloma: a randomized phase 2 trial by the Nordic Myeloma Study Group

Autor:	Nielsen, Lene K., Schjesvold, Fredrik, Möller, Sören, Guldbrandsen, Nina, Hansson, Markus, Remes, Kari, Peceliunas, Valdas, Abildgaard, Niels, Gregersen, Henrik, King, Madeleine T.
Zdroj:	Jo
Databáze:	NORA (Norwegian Open Research Archive)
Externí odkaz:	http://hdl.handle.net/10852/107581 Zobrazit plný text záznamu